The cost-effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030.

Yinzong Xiao,Margaret E Hellard,Alexander J Thompson,Christopher Seaman,Jess Howell,Nick Scott

The Medical journal of Australia（2023）

引用 2|浏览15

暂无评分

摘要

Universal screening for hepatitis B will be cost-effective only if the cost of testing is kept low and people receive appropriate clinical management.

查看译文

关键词

Economics, medical,Hepatitis B,Mass screening,Public health

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要